Whole-Body Biodistribution and Radiation Dosimetry of <sup>18</sup>F-GE067: A Radioligand for In Vivo Brain Amyloid Imaging - Concepedia

Concepedia

Publication | Open Access

Whole-Body Biodistribution and Radiation Dosimetry of <sup>18</sup>F-GE067: A Radioligand for In Vivo Brain Amyloid Imaging

DOI Full Paper Access

208

Citations

15

References

2009

Year

Michel Koole, Dewi M. Lewis, Christopher Buckley, Natalie Nelissen, Mathieu Vandenbulcke, David J. Brooks, Rik Vandenberghe, Koen Van Laere

Journal of Nuclear Medicine

Abstract

The estimated effective dose of (18)F-GE067 for PET amyloid imaging was acceptable (class II-b defined by the World Health Organization), and relatively low variability between subjects was observed.

References

	Year	Citations
Imaging brain amyloid in Alzheimer's disease with Pittsburgh Compound‐B William E. Klunk, Henry Engler, Agneta Nordberg, Annals of Neurology NeuropsychologyBrain FunctionNovel TracerCorticobasal DegenerationSocial Sciences	2004	4.4K
Post-mortem correlates of in vivo PiB-PET amyloid imaging in a typical case of Alzheimer's disease Miloš D. Ikonomović, William E. Klunk, Eric E. Abrahamson, Brain	2008	921
PET of Brain Amyloid and Tau in Mild Cognitive Impairment Gary W. Small, Vladimir Kepe, Linda M. Ercoli, New England Journal of Medicine	2006	732
Imaging of amyloid β in Alzheimer's disease with 18F-BAY94-9172, a novel PET tracer: proof of mechanism Christopher C. Rowe, Uwe Ackerman, William F. Browne, The Lancet Neurology Positron Emission TomographyAmyloid βNeurodegenerative DiseasesNeuroimaging BiomarkersAlzheimer's Disease	2008	664
In-Vivo Imaging of Alzheimer Disease -Amyloid With [11C]SB-13 PET N. P. L. G. Verhoeff American Journal of Geriatric Psychiatry Positron Emission TomographyNeurodegenerative DiseasesAlzheimer's DiseaseEngineeringPet-mri	2004	316
Aβ deposits in older non-demented individuals with cognitive decline are indicative of preclinical Alzheimer's disease Victor L. Villemagne, Kerryn E. Pike, David Darby, Neuropsychologia Neurodegenerative DiseasesAlzheimer's DiseaseAgingOlder Non-demented IndividualsMedicine	2008	287
<i>Limits for Intakes of Radionuclides by Workers</i>. <i>ICRP Publication 30</i>, <i>Part 3</i> D. G. Cadena Medical Physics	1983	226
Safety, biodistribution, and dosimetry of 123I-IMPY: a novel amyloid plaque-imaging agent for the diagnosis of Alzheimer's disease. Andrew B. Newberg, Nancy Wintering, John Hochold, PubMed	2006	144
Binding of two potential imaging agents targeting amyloid plaques in postmortem brain tissues of patients with Alzheimer's disease Mei‐Ping Kung, Catherine Hou, Zhi‐Ping Zhuang, Brain Research Neuroimaging BiomarkersAlzheimer's DiseaseAmyloid PlaquesDementiaVascular Dementia	2004	133
Radiation Dosimetry of β-Amyloid Tracers <sup>11</sup>C-PiB and <sup>18</sup>F-BAY94-9172 Graeme O’Keefe, Timothy Saunder, Steven Ng, Journal of Nuclear Medicine	2009	77

Page 1